The product is intended for scientific research and development purposes only
10.1016/j.cellsig.2023.110689 Summary Keywords clinical transition, dual inhibitors, phosphodiesterase 10A, phosphodiesterase 1B, schizophrenia Citation Rautela J, Gaurav A, Nissapatorn V, Tan CK, Girol AP, Pereira MDL and Lee VS (2026) PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise
A study evaluating different antioxidants found that, in controlled doses, glutathione reduces cell oxidation levels by up to 30% more than vitamin C and by 20% more than vitamin E after four weeks' use 1
Schema Markup
30 servings per bottle
The authors concluded that GHK-Cu accelerates wound healing and skin repair through coordinated effects on collagen and glycosaminoglycan turnover, modulation of metalloproteinase activity, attraction of immune and endothelial cells to injury sites, and restoration of replicative vitality in irradiated fibroblasts [1]